logo

XLO

Xilio Therapeutics·NASDAQ
--
--(--)
--
--(--)

XLO fundamentals

Xilio Therapeutics (XLO) released its earnings on Aug 14, 2025: revenue was 8.09M (YoY +243.01%), missed estimates; EPS was -2.24 (YoY +33.33%), missed estimates.
Revenue / YoY
8.09M
+243.01%
EPS / YoY
-2.24
+33.33%
Report date
Aug 14, 2025
Earnings Call
7:30 AM on Aug 14, 2025
Meeting link.
EPS
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-297.78-13.72-10.92-12.6-10.08-11.48-11.62-9.8-8.54-8.96-8.68-3.36-3.08-2.8-2.52-2.24
Forecast
-15.2133-15.568-14.112-10.955-12.285-10.99-12.39-12.145-11.305-8.715-1.54-3.22-3.4533-3.0338-2.6978-1.1032
Surprise
-1857.37%
+11.87%
+22.62%
-15.02%
+17.95%
-4.46%
+6.21%
+19.31%
+24.46%
-2.81%
-463.64%
-4.35%
+10.81%
+7.71%
+6.59%
-103.05%
Revenue
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
000000000002.36M2.28M1.72M2.92M8.09M
Forecast
000000000030.00M30.00M3.30M3.30M4.40M8.21M
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-100.00%
-92.14%
-30.91%
-47.76%
-33.75%
-1.46%

Earnings Call